South America Sepsis Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 172    |    Report Code: BMIRE00025666    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Sepsis Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South America Sepsis Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South America Sepsis Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 High sepsis mortality rates
  • 5.1.2 Need for rapid diagnosis
5.2 Market Opportunities
  • 5.2.1 Development of POC diagnostics
  • 5.2.2 Use of biomarkers
5.3 Future Trends
  • 5.3.1 Demand in critical care settings
  • 5.3.2 Government initiatives for better diagnostics
5.4 Impact of Drivers and Restraints

6. South America Sepsis Diagnostics Market Regional Analysis

6.1 South America Sepsis Diagnostics Market Overview
6.2 South America Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 South America Sepsis Diagnostics Market Forecast Analysis

7. South America Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: South America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: South America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: South America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: South America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Flow Cytometry
  • 8.2.1 Overview
  • 8.2.2 Flow Cytometry: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Microfluidics
  • 8.3.1 Overview
  • 8.3.2 Microfluidics: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunoassay
  • 8.4.1 Overview
  • 8.4.2 Immunoassay: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Biomarkers
  • 8.5.1 Overview
  • 8.5.2 Biomarkers: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Microbiology
  • 8.6.1 Overview
  • 8.6.2 Microbiology: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Microbiology: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Sepsis Diagnostics Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South America Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 South America Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.1.2 Brazil: South America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 Brazil: South America Sepsis Diagnostics Market Breakdown, by Method
  • 10.1.1.2 Argentina: South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.2.2 Argentina: South America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 Argentina: South America Sepsis Diagnostics Market Breakdown, by Method
  • 10.1.1.3 Rest of South and Central America : South America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.3.2 Rest of South and Central America : South America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Rest of South and Central America : South America Sepsis Diagnostics Market Breakdown, by Method

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South America Sepsis Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Immunexpress Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Danaher (Beckman Coulter)
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Luminex Corporation
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 bioMerieux SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 T2 Biosystems, Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South America Sepsis Diagnostics Market

  1. Abbott
  2. F. HOFFMANN-LA ROCHE LTD.
  3. Immunexpress Inc.
  4. BD
  5. Danaher (Beckman Coulter)
  6. Luminex Corporation
  7. THERMO FISHER SCIENTIFIC INC.
  8. bioMerieux SA
  9. T2 Biosystems, Inc
south-america-sepsis-diagnostics-market